Article
An intermittent rocking platform for integrated expansion and differentiation of human pluripotent stem cells to cardiomyocytes in suspended microcarrier cultures.
Stem cell research - 1 Sept 2014
Ting Sherwin, Chen Allen, Reuveny Shaul, Oh Steve
Abstract excerpt
The development of novel platforms for large scale production of human embryonic stem cells (hESC) derived cardiomyocytes (CM) becomes more crucial as the demand for CMs in preclinical trials, high throughput cardio toxicity assays and future regenerative therapeutics rises. To this end, we have designed a microcarrier (MC) suspension agitated platform that integrates pluripotent hESC expansion followed by CM...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
